Dipyridamole-induced angina pectoris during sestamibi stress test in patients with significant coronary artery disease: Clinical, angiographic, and nuclear determinants

Angiology

Volumn 48, Issue 4, 1997, Pages 301-307

  Rosseel, M ^a,b   Dendale, P ^a   De Sadeleer, C ^a   Schoors, D ^a   Block, P ^a   Franken, P R ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CELL VIABILITY; COLLATERAL CIRCULATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DRUG INDUCED DISEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030984591     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704800403     Document Type: Article

References (20)

1. Leppo J, Depuey E, Johnson L: A review of cardiac imaging with sestamibi and teburoxime. J Nucl Med 32:2012-2022, 1991.
2. Feldman RL, Pepine C: Acute effect of intravenous dipyridamole on regional coronary hemodynamics and metabolism. Circulation 64:333-344, 1981.
3. Gould K, Westcott R, Albro P, et al; Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologie coronary vasodilatation. Am J Cardiol 41:279-287, 1978.
4. Chambers C, Brown K: Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: Angiographie and hemodynamic determinants. J Am Coll Cardiol 12:37-41, 1988.
5. Gould K: Coronary steal, is it clincally important? Chest 96:227-228, 1989.
6. Zhu Y, Lee W, Dae M, Chatterjee K, et al: The significance of induced cardiac pain during dipyridamole scintigraphy (abstract). J Am Coll Cardiol 9:121A, 1987.
7. Diabizzi P, Barletta G, Lo Sapio P, et al: Dipyridamole angina: A specific symptom of severe multivessel disease. Coronary Artery Disease Angiology 5:365-368, 1994.
8. Killip T: Coronary artery surgery study (CASS). Circulation 63(suppl I):l-39, 1981.
9. Fujita M, Mikuniya A, Mckown D, et al: Effects of dipyridamole on collateral flow and regional myocardial function in conscious dogs with newly developed collaterals. Basic Res Cardiol 85:142-152, 1990.
10. Harrison D, Simonetti I: Neurohumeral regulation of collateral perfusion. Circulation 83:62-67, 1991.
11. Sabia P, Powers E, Ragosta M, et al: An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 327:1825-1831, 1992.
12. Fuster V, Frye R, Kennedy M, et al: The role of collateral circulation in various coronary syndromes. Circulation 59:1137-1144, 1979.
13. Mizuno K, Horiuchi K, Matui H, et al: Role of collateral coronary vessels during transient coronary occlusion during angioplasty assessed by hemodynamic, electrocardiographic and metabolic changes. J Am Coll Cardiol 12:624-628, 1988.
14. Calvin E, Patterson R, Horowitz S, et al: Coronary collateral function during exercise. Circulation 66:309-316, 1982.
15. Cohen M, Rentrop K: Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: A prospective study. Circulation 74:469-476, 1986.
16. Gregg D, Patterson R: Current concepts. Functional importance of the coronary collaterals. N Engl J Med 303:1404-1406, 1980.
17. Hansen J: Coronary collateral circulation: Clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 117:290-295, 1989.
18. Kolibash A, Bush C, Wepsic R, et al: Coronary collateral vessels: Spectrum of physiologic capabilities with respect to providing rest and stress myocardial perfusion, maintenance of left ventricular function and protection against infarction. Am J Cardiol 50:230-238, 1982.
19. Fujita M, Ohno A, Wada O, et al: Collateral circulation as a marker of the presence of viable myocardium in patients with recent myocardial infarction. Am Heart J 122:409-414, 1991.
20. Crane P, Laliberte R, Heminway S, et al: Effect of mitochondrial viability and metabolism on technetium99m-sestamibi myocardial retention. Eur J Nucl Med 20:20-25, 1993.